Diagnostic Laboratory Workup for Erythrocytosis
The essential laboratory workup for erythrocytosis should include complete blood count with peripheral blood smear, JAK2 V617F mutation testing, and serum erythropoietin level as first-line tests to differentiate between primary and secondary causes. 1
Initial Laboratory Assessment
First-line Testing
- Complete blood count (CBC) with differential - To confirm erythrocytosis and assess other cell lines 2, 1
- Peripheral blood smear - To evaluate red cell morphology and identify abnormalities in other cell lines 1
- JAK2 V617F mutation testing - To identify the most common genetic marker of polycythemia vera 1, 3
- Serum erythropoietin level - To distinguish between primary and secondary erythrocytosis 1, 3
Second-line Testing
- JAK2 exon 12 mutation testing - If JAK2 V617F is negative but PV still suspected 1
- Bone marrow aspirate and biopsy with immunohistochemistry - To assess cellularity and exclude other myeloproliferative disorders 2, 1
- Serum ferritin and transferrin saturation - To evaluate iron status 2
- Reticulocyte count - To assess bone marrow response to erythrocytosis 2
Diagnostic Algorithm
Confirm true erythrocytosis:
- Elevated hemoglobin/hematocrit above the 95th percentile adjusted for sex and race 1
- Rule out relative erythrocytosis due to dehydration
Determine if primary or secondary:
- If JAK2 mutation positive AND low/normal serum erythropoietin: Likely polycythemia vera 1, 3
- If JAK2 mutation negative AND elevated serum erythropoietin: Likely secondary erythrocytosis 3
- If JAK2 mutation negative AND low/normal serum erythropoietin: Consider JAK2 exon 12 testing and bone marrow biopsy 1
For suspected secondary erythrocytosis, evaluate:
Special Considerations
- Caution with interpretation: Some patients with polycythemia vera may have normal or even elevated erythropoietin levels, especially during acute bleeding episodes or early in disease course 6
- Iron deficiency: Can mask true hemoglobin/hematocrit levels in PV patients 1
- Sodium-glucose cotransporter 2 (SGLT2) inhibitors: Can induce erythrocytosis or unmask underlying PV 5
- Primary thrombocythemia: May present with low erythropoietin levels and high-normal hemoglobin 7
Pitfalls to Avoid
- Relying solely on erythropoietin levels: While low levels are highly specific for PV, approximately 13% of PV patients may have normal erythropoietin levels 4
- Overlooking JAK2 exon 12 mutations: These account for ~3% of PV cases that are JAK2 V617F negative 1
- Repeated phlebotomies without diagnosis: Can lead to iron deficiency, decreased oxygen-carrying capacity, and increased stroke risk 2, 1
- Missing secondary causes: Comprehensive evaluation for hypoxic conditions, renal disease, and medications (especially androgens) is essential 1, 5
By following this systematic approach to laboratory testing, the underlying cause of erythrocytosis can be identified efficiently, allowing for appropriate management to reduce morbidity and mortality from thrombotic complications.